Health Canada conditionally approved Leqembi (lecanemab) to treat mild cognitive impairment or dementia due to early ...

Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis is establishing a new center dedicated to developing AI-based imaging tools to improve the diagnosis ...

New research in Medicine & Science in Sports & Exercise suggests exercise may be one way to boost that self-control. Specifically, researchers found that an aerobic activity protocol improved ...

Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of John Harrison as Clinical Vice President. As drug developers face growing demand for ...

Access to nutritious food through SNAP slows cognitive decline, but barriers limit the program's reach and effectiveness on ...

Neuroscientist Gerald Voelbel’s journey from mysterious symptoms to a rare cancer and neurological disorder diagnosis highlights the power of self-advocacy and finding purpose.

An X chromosome gene appears to drive inflammation in the brain, and may explain why women are more likely to develop MS, per a study.

AstaReal Inc. announces the first virtual symposium hosted by the AstaReal Network for Sports Nutrition (ANSN) on November 12–13, 2025. Launched in 2023, ANSN is a global initiative advancing the ...

Baszucki Group is proud to announce the six recipients of the first-ever Metabolic Psychiatry Scholar Award, a new initiative that supports exceptional early-career scientists and clinicians working ...